Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Jul 1;160(1):29–41. doi: 10.1084/jem.160.1.29

Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta

PMCID: PMC2187434  PMID: 6376683

Abstract

We have recently reported that human pregnancy is characterized by a 10- to 20-fold elevation of eosinophil major basic protein (MBP) immunoreactivity in maternal blood. Here we show, by immunofluorescence, that placental tissue specifically binds antibody to MBP in and around the placental X cells and placental-site giant cells and, using thin plastic sections, that placenta has no infiltrating eosinophils. The X cells line the inner aspects of placental septal cysts, and the cyst fluid, obtained by aspiration, contains immunoreactive MBP at concentrations of 100 micrograms/ml, a sixfold greater concentration than the highest levels measured in maternal blood. The soluble MBP immunoreactivities in placental homogenates and in maternal serum chromatograph identically on Sephadex G-50, and both these gestational MBP molecules migrate as though substantially larger than the MBP found in serum from patients with hypereosinophilic syndrome or purified from the eosinophil granule. Our inability to demonstrate eosinophils in maternal blood or placental tissue, coupled with the large quantities of immunoreactive MBP highly localized in placental cysts and the chromatographic behavior of this molecule, suggest that the MBP detected in human gestation is produced by placenta.

Full Text

The Full Text of this article is available as a PDF (2.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman S. J., Gleich G. J., Weller P. F., Ottesen E. A. Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis. J Immunol. 1981 Sep;127(3):1093–1098. [PubMed] [Google Scholar]
  2. Ackerman S. J., Kephart G. M., Habermann T. M., Greipp P. R., Gleich G. J. Localization of eosinophil granule major basic protein in human basophils. J Exp Med. 1983 Sep 1;158(3):946–961. doi: 10.1084/jem.158.3.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Butterworth A. E., Wassom D. L., Gleich G. J., Loegering D. A., David J. R. Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol. 1979 Jan;122(1):221–229. [PubMed] [Google Scholar]
  4. Ermocilla R., Altshuler G. The origin of "X cells" of the human placenta and their possible relationship to intrauterine growth retardation: an enigma. Am J Obstet Gynecol. 1973 Dec 15;117(8):1137–1140. doi: 10.1016/0002-9378(73)90765-5. [DOI] [PubMed] [Google Scholar]
  5. Filley W. V., Ackerman S. J., Gleich G. J. An immunofluorescent method for specific staining of eosinophil granule major basic protein. J Immunol Methods. 1981;47(2):227–238. doi: 10.1016/0022-1759(81)90123-x. [DOI] [PubMed] [Google Scholar]
  6. Frigas E., Loegering D. A., Gleich G. J. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest. 1980 Jan;42(1):35–43. [PubMed] [Google Scholar]
  7. Frigas E., Loegering D. A., Solley G. O., Farrow G. M., Gleich G. J. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc. 1981 Jun;56(6):345–353. [PubMed] [Google Scholar]
  8. Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979 Dec;123(6):2925–2927. [PubMed] [Google Scholar]
  9. Gleich G. J., Loegering D. A., Maldonado J. E. Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med. 1973 Jun 1;137(6):1459–1471. doi: 10.1084/jem.137.6.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gleich G. J., Loegering D. A., Mann K. G., Maldonado J. E. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest. 1976 Mar;57(3):633–640. doi: 10.1172/JCI108319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Khudr G., Soma H., Benirschke K. Trophoblastic origin of the X cell and the placental site giant cell. Am J Obstet Gynecol. 1973 Feb 15;115(4):530–533. doi: 10.1016/0002-9378(73)90402-x. [DOI] [PubMed] [Google Scholar]
  12. Kierszenbaum F., Ackerman S. J., Gleich G. J. Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein. Am J Trop Med Hyg. 1981 Jul;30(4):775–779. doi: 10.4269/ajtmh.1981.30.775. [DOI] [PubMed] [Google Scholar]
  13. Kim C. K., Benirschke K. Autoradiographic study of the "X cells" in the human placenta. Am J Obstet Gynecol. 1971 Jan 1;109(1):96–102. doi: 10.1016/0002-9378(71)90841-6. [DOI] [PubMed] [Google Scholar]
  14. Lewis D. M., Lewis J. C., Loegering D. A., Gleich G. J. Localization of the guinea pig eosinophil major basic protein to the core of the granule. J Cell Biol. 1978 Jun;77(3):702–713. doi: 10.1083/jcb.77.3.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Maddox D. E., Butterfield J. H., Ackerman S. J., Coulam C. B., Gleich G. J. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein. J Exp Med. 1983 Oct 1;158(4):1211–1226. doi: 10.1084/jem.158.4.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Maidman J. E., Thorpe L. W., Harris J. A., Wynn R. M. Fetal origin of x-cells in human placental septa and basal plate. Obstet Gynecol. 1973 Apr;41(4):547–552. [PubMed] [Google Scholar]
  17. O'Donnell M. C., Ackerman S. J., Gleich G. J., Thomas L. L. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med. 1983 Jun 1;157(6):1981–1991. doi: 10.1084/jem.157.6.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Peters M. S., Schroeter A. L., Kephart G. M., Gleich G. J. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol. 1983 Jul;81(1):39–43. doi: 10.1111/1523-1747.ep12538380. [DOI] [PubMed] [Google Scholar]
  19. Sutcliffe R. G., Davies M., Hunter J. B., Waters J. J., Parry J. E. The protein composition of the fibrinoid material at the human uteroplacental interface. Placenta. 1982 Jul-Sep;3(3):297–308. doi: 10.1016/s0143-4004(82)80006-4. [DOI] [PubMed] [Google Scholar]
  20. Wassom D. L., Loegering D. A., Gleich G. J. Measurement of guinea pig eosinophil major basic protein by radioimmunoassay. Mol Immunol. 1979 Sep;16(9):711–719. doi: 10.1016/0161-5890(79)90012-9. [DOI] [PubMed] [Google Scholar]
  21. Wassom D. L., Loegering D. A., Solley G. O., Moore S. B., Schooley R. T., Fauci A. S., Gleich G. J. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest. 1981 Mar;67(3):651–661. doi: 10.1172/JCI110080. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES